Method and system of controlling conductive fluid flow during an electrosurgical procedure

Information

  • Patent Grant
  • 9801678
  • Patent Number
    9,801,678
  • Date Filed
    Wednesday, March 13, 2013
    11 years ago
  • Date Issued
    Tuesday, October 31, 2017
    7 years ago
Abstract
Controlling conductive fluid flow during an electrosurgical procedure. At least some of the example embodiments are methods including: flowing conductive fluid from a source lumen to a suction lumen of an electrosurgical wand, the flowing with the electrosurgical wand in a first orientation; sensing a change in orientation of the electrosurgical wand to a second orientation different than the first orientation; and changing a control parameter associated with the conductive fluid flow, the changing responsive to the change in orientation of the electrosurgical wand.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

None.


BACKGROUND

Electrosurgical procedures can be classified, at some level, based on the location associated with the body at which the procedure takes place. “Wet field” procedures generally take place inside the body, such as within the shoulder or within the knee. “Dry field” procedures generally take place on an outer surface of the body or surfaces exposed to atmosphere, such as the skin, within the mouth, or within the nasopharynx.


Regardless of whether a procedure is a wet field or dry field procedure, in most cases saline is delivered to the treatment site; however, in dry field procedures excess saline can easily migrate and cause secondary issues. For example, excess saline accumulating in the throat during procedures in the nose or mouth can cause unintended flow paths for electrical current through the body, or may allow the saline to enter the lungs.


Any advance that better controls saline fluid in and around the electrodes of an electrosurgical system would provide a competitive advantage.





BRIEF DESCRIPTION OF THE DRAWINGS

For a detailed description of exemplary embodiments, reference will now be made to the accompanying drawings in which:



FIG. 1 shows an electrosurgical system in accordance with at least some embodiments;



FIG. 2 shows a perspective view a portion of a wand in accordance with at least some embodiments;



FIG. 3 shows an elevation view of a system in order to describe shortcomings of the related-art;



FIG. 4 shows an elevation view of a system in order to describe shortcomings of the related-art;



FIG. 5 shows an elevation view of a system in order to describe shortcomings of the related-art;



FIG. 6 shows an elevation view of a (partial) system in accordance with at least some embodiments;



FIG. 7 shows a schematic diagram of a flow control device in accordance with at least some embodiments;



FIG. 8 shows a schematic diagram of a flow control device in accordance with at least some embodiments;



FIG. 9 shows an electrical block diagram of an electrosurgical controller in accordance with at least some embodiments;



FIG. 10 shows an elevation view of a (partial) system in accordance with at least some embodiments;



FIG. 11 shows an electrical block diagram of a flow control device in accordance with at least some embodiments; and



FIG. 12 shows a method in accordance with at least some embodiments.





NOTATION AND NOMENCLATURE

Certain terms are used throughout the following description and claims to refer to particular system components. As one skilled in the art will appreciate, companies that design and manufacture electrosurgical systems may refer to a component by different names. This document does not intend to distinguish between components that differ in name but not function.


In the following discussion and in the claims, the terms “including” and “comprising” are used in an open-ended fashion, and thus should be interpreted to mean “including, but not limited to . . . .” Also, the term “couple” or “couples” is intended to mean either an indirect or direct connection. Thus, if a first device couples to a second device, that connection may be through a direct connection or through an indirect connection via other devices and connections.


Reference to a singular item includes the possibility that there are plural of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said” and “the” include plural references unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement serves as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Lastly, it is to be appreciated that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.


“Active electrode” shall mean an electrode of an electrosurgical wand which produces an electrically-induced tissue-altering effect when brought into contact with, or close proximity to, a tissue targeted for treatment.


“Return electrode” shall mean an electrode of an electrosurgical wand which serves to provide a current flow return path with respect to an active electrode, and/or an electrode of an electrical surgical wand which does not itself produce an electrically-induced tissue-altering effect on tissue targeted for treatment.


A fluid conduit said to be “within” an elongate housing shall include not only a separate fluid conduit that physically resides within an internal volume of the elongate housing, but also situations where the internal volume of the elongate housing is itself the fluid conduit.


“Orientation”, with regard to an electrosurgical wand, shall mean inclination of the distal end of wand relative to the handle end of the wand, elevation of the distal end of the wand (e.g., relative to a source of conductive fluid), rotational orientation of the wand, or a combination thereof.


“Three-axis gyroscope” shall refer to a sensor that senses positional changes in position in all three spatial directions.


“Six-axis gyroscope” shall refer to a sensor that senses positional changes in position in all three spatial directions, and also senses acceleration in all three spatial directions.


Where a range of values is provided, it is understood that every intervening value, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein.


All existing subject matter mentioned herein (e.g., publications, patents, patent applications and hardware) is incorporated by reference herein in its entirety except insofar as the subject matter may conflict with that of the present invention (in which case what is present herein shall prevail). The referenced items are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such material by virtue of prior invention.


DETAILED DESCRIPTION

Before the various embodiments are described in detail, it is to be understood that this invention is not limited to particular variations set forth herein as various changes or modifications may be made, and equivalents may be substituted, without departing from the spirit and scope of the invention. As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present invention. In addition, many modifications may be made to adapt a particular situation, material, composition of matter, process, process act(s) or step(s) to the objective(s), spirit or scope of the present invention. All such modifications are intended to be within the scope of the claims made herein.



FIG. 1 illustrates an electrosurgical system 100 in accordance with at least some embodiments. In particular, the electrosurgical system comprises an electrosurgical wand 102 (hereinafter “wand”) coupled to an electrosurgical controller 104 (hereinafter “controller”). The wand 102 comprises an elongate housing 106 that defines distal end 108 where at least some electrodes are disposed. The elongate housing 106 further defines a handle or proximal end 110. The wand 102 further comprises a flexible multi-conductor cable 112 housing a plurality of electrical and/or communicative conductors (not specifically shown in FIG. 1), and the flexible multi-conductor cable 112 terminates in a wand connector 114. As shown in FIG. 1, the wand 102 couples to the controller 104, such as by a controller connector 120 on an outer surface 122 (in the illustrative case of FIG. 1, the front surface).


Though not visible in the view of FIG. 1, in some embodiments the wand 102 has one or more internal fluid conduits coupled to externally accessible tubular members. As illustrated, the wand 102 has a first flexible tubular member 116 and a second flexible tubular member 118. In some embodiments, the flexible tubular member 116 is used to provide a conductive fluid (e.g., saline) to the distal end 108 of the wand. In an example system, the flexible tubular member 116 is a hose or tubing having a 0.152 inch outside diameter, and a 0.108 inch inside diameter, but other sizes may be equivalently used. In the example system of FIG. 1, the source of the conductive fluid is a saline bag 150, with the saline flowing through an intermediate flow control device 152 prior to reaching the wand 102. The flow control strategy implemented by the flow control device 152 is discussed in greater detail below. The flow control device 152 comprises a flexible multi-conductor cable 154 housing a plurality of electrical and/or communicative conductors (not specifically shown in FIG. 1), and the flexible multi-conductor cable 154 terminates in a connector 156. As shown in FIG. 1, the flow control device couples to the controller 104, such as by a controller connector 158 on an outer surface 122 (in the illustrative case of FIG. 1, the front surface). Thus, in the example system the electrosurgical controller 104 communicatively couples to and controls operation of the flow control device 152.


In some embodiments, flexible tubular member 118 is used to provide suction for aspiration at the distal end 108 of the wand. The suction for aspiration may be provided from any suitable source (e.g., wall suction in a hospital environment, or suction provided from a peristaltic pump). In one example system, the flexible tubular member 118 is a hose having a 0.25 inch outside diameter, and a 0.17 inch internal diameter, but other sizes may be equivalently used.


Still referring to FIG. 1, the controller 104 controllably provides energy to the wand 102 for the electrosurgical procedures (discussed more below). A display device or interface panel 124 is visible through the outer surface 122 of the controller 104, and in some embodiments a user may select operational modes of the controller 104 by way of the interface device 124 and related buttons 126.


In some embodiments the electrosurgical system 100 also comprises a foot pedal assembly 130. The foot pedal assembly 130 may comprise one or more pedal devices 132 and 134, a flexible multi-conductor cable 136 and a pedal connector 138. While only two pedal devices 132, 134 are shown, one or more pedal devices may be implemented. The outer surface 122 of the controller 104 may comprise a corresponding connector 140 that couples to the pedal connector 138. The foot pedal assembly 130 may be used to control various aspects of the controller 104, such as the operational mode. For example, a pedal device, such as pedal device 132, may be used for on-off control of the application of radio frequency (RF) energy to the wand 102. A second pedal device, such as pedal device 134, may be used to control and/or set the operational mode of the electrosurgical system. For example, actuation of pedal device 134 may switch between energy levels. In yet still further embodiments, the wand 102 may further comprise switches accessible on an outside portion, where the switches may control the operational modes of the controller 104.


The electrosurgical system 100 of the various embodiments may have a variety of operational modes. One such mode employs Coblation® technology. In particular, the assignee of the present disclosure is the owner of Coblation® technology. Coblation® technology involves the application of a RF energy between one or more active electrodes and one or more return electrodes of the wand 102 to develop high electric field intensities in the vicinity of the target tissue. The electric field intensities may be sufficient to vaporize an electrically conductive fluid over at least a portion of the one or more active electrodes in the region near the one or more active electrodes and the target tissue. Electrically conductive fluid may be inherently present in the body, such as blood, puss, or in some cases extracellular or intracellular fluid. In other embodiments, the electrically conductive fluid may be a liquid or gas, such as isotonic saline. In a particular embodiment of wound treatment, the electrically conductive fluid is delivered in the vicinity of the active electrode and/or to the target site by the wand 102, such as by way of the internal fluid conduit and flexible tubular member 116.


When the electrically conductive fluid is heated to the point that the atoms of the fluid vaporize faster than the atoms recondense, a gas is formed. When sufficient energy is applied to the gas, the atoms collide with each other causing a release of electrons in the process, and an ionized gas or plasma is formed (the so-called “fourth state of matter”). Stated otherwise, plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through the gas, or by directing electromagnetic waves into the gas. The methods of plasma formation give energy to free electrons in the plasma directly, electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference.


As the density of the plasma becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases such that subsequently injected electrons cause impact ionization within the plasma. When the ionic particles in the plasma layer have sufficient energy (e.g., 3.5 electron-Volt (eV) to 5 eV), collisions of the ionic particles with molecules that make up the target tissue break molecular bonds of the target tissue, dissociating molecules into free radicals which then combine into gaseous or liquid species. Often, the electrons in the plasma carry the electrical current or absorb the electromagnetic waves and, therefore, are hotter than the ionic particles. Thus, the electrons, which are carried away from the target tissue toward the active or return electrodes, carry most of the plasma's heat, enabling the ionic particles to break apart the target tissue molecules in a substantially non-thermal manner.


By means of the molecular dissociation (as opposed to thermal evaporation or carbonization), the target tissue is volumetrically removed through molecular dissociation of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. The molecular dissociation completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as occurs in related art electrosurgical desiccation and vaporization. A more detailed description of the molecular dissociation can be found in commonly assigned U.S. Pat. No. 5,697,882, the complete disclosure of which is incorporated herein by reference.


In addition to the Coblation® mode, the electrosurgical system 100 of FIG. 1 may also in particular situations be useful for sealing blood vessels, when used in what is known as a coagulation mode. Thus, the system of FIG. 1 may have an ablation mode where RF energy at a first voltage is applied to one or more active electrodes sufficient to effect molecular dissociation or disintegration of the tissue, and the system of FIG. 1 may have a coagulation mode where RF energy at a second, lower voltage is applied to one or more active electrodes sufficient to heat, shrink, seal, fuse, and/or achieve homeostasis of severed vessels within the tissue.


The energy density produced by electrosurgical system 100 at the distal end 108 of the wand 102 may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and/or sharp edges on the electrode surfaces; electrode materials; applied voltage; current limiting of one or more electrodes (e.g., by placing an inductor in series with an electrode); electrical conductivity of the fluid in contact with the electrodes; density of the conductive fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the electrosurgical system 100 may be configured to produce energy sufficient to break the molecular bonds of certain tissue but insufficient to break the molecular bonds of other tissue.


A more complete description of the various phenomena can be found in commonly assigned U.S. Pat. Nos. 6,355,032; 6,149,120 and 6,296,136, the complete disclosures of which are incorporated herein by reference.



FIG. 2 illustrates a perspective view of the distal end 108 of wand 102 in accordance with an example system. In particular, in the example system the wand 102 is a wound care wand enabled for use to treat wounds on a patient's skin. Other types of wands may be used in the example system. For example, the PROCISE® Max Plasma Wand available from AthroCare Corporation of Austin, Tex., is designed and constructed for use in the mouth and throat may be used, such as for tonsillectomies. As a further example, wands designed in constructed for use in the nasopharynx may be used, such as for removal of portions of the soft palate and/or removal of polyps for treatment of sleep apnea. The relative proportions of the components of wands designed for different treatments will differ, but regardless of size and proportion wands for dry field use will comprise the same base components: an active electrode; a return electrode; a source or discharge lumen from which conductive fluid flows; and a suction or aspiration lumen in which conductive fluid and ablated tissue is aspirated away from the treatment site.


The illustrative wand 102 of FIG. 2 has a suction lumen 200, two active electrodes 202 and 204, a support member 206, a source lumen 208, and a return electrode 210. The support member 206 is coupled to the elongate housing 106. In a particular embodiment, the elongate housing 106 and handle 110 (FIG. 1) are made of a non-conductive plastic material, such as polycarbonate. In yet other embodiments, the handle 110 and/or elongate housing 106 may be constructed in whole or in part of metallic material, but the metallic material may be non-grounded and/or not provide a return path for electrons to the controller 104. Further, support member 206 is a non-conductive material resistant to degradation when exposed to plasma. In some cases support member 206 is made of a ceramic material (e.g., alumina ceramic), but other non-conductive materials may be equivalently used (e.g., glass).


An illustrative two active electrodes 202 and 204 are coupled to the support member 206. Each active electrode is a metallic structure, around which plasma is created during use in some operational modes. In some case, the wire is stainless steel, but other types of metallic wire (e.g., tungsten, molybdenum) may be equivalently used. As illustrated, each active electrode 202 and 204 is a loop of wire having a particular diameter. In wands designed for other uses (e.g., ablation of tissue of the soft palate), the active electrode may take the form of a screen or metallic plate with one or more apertures through the metallic plate leading to the suction lumen. Each example active electrode 202 and 204 is electrically coupled to the controller 104 (FIG. 1). In some cases, the active electrodes 202 and 204 are coupled to the controller by way of respective standoff portions and an insulated conductor (not specifically shown) that runs through the elongate housing 106. Thus, by way of the cable 112 (FIG. 1) and electrical pins (shown and discussed below) in the connector 114 (FIG. 1), the active electrodes 202 and 204 couple to the controller 104 (FIG. 1).



FIG. 2 further shows a source lumen 208. The source lumen 208 as illustrated is rectangular, where the long dimension is aligned with the width W. Rectangular shaped source lumen are merely illustrative, and any suitable shape may be equivalently used (e.g., circular, oval, square). The source lumen 208 is fluidly coupled within the elongate housing 106 to flexible tubular member 116 (FIG. 1), through which conductive fluids flow during use. Thus, during use, conductive fluid flows into the flexible tubular member 116 (FIG. 1), through one or more fluid conduits (not specifically shown) within the elongate housing 106, and out of the source lumen 208.


The distal end 108 of the example wand 102 further comprises a return electrode in the form of a conductive plate 210. In particular, the conductive plate 210 abuts the source lumen 208, and in the embodiments of FIG. 2 a portion of the conductive plate 210 at least partially defines the outer aperture of the source lumen 208. The conductive plate 210 is made of conductive material, which conductive material forms a return path for electrical current associated with energy applied to the active electrodes. In some cases the conductive plate 210 is made of stainless steel, but other types of metals (e.g., tungsten, molybdenum) may be equivalently used. The illustrative conductive plate 210 is oriented such that at least some of the saline flowing through the fluid conduit 218 contacts the conductive plate 210 before contacting an adjacent wound or contacting the active electrodes 202 and 204. Conductive plate 210 is electrically coupled to the controller 104 (FIG. 1). In some cases, the conductive plate 210 is coupled to the controller by way of an insulated conductor (not specifically shown) that runs through the elongate housing 106. Thus, by way of the cable 112 (FIG. 1) and electrical pins in the connector 114 (FIG. 1), the conductive plate 210 couples to the controller 104 (FIG. 1).



FIG. 2 also illustrates that a wand 102 in accordance with at least some embodiments further comprises a suction lumen 200. The suction lumen 200 is fluidly coupled to the flexible tubular member 118 (FIG. 1) by way of fluid conduit (not specifically shown) within the wand 102. Thus, and as the name implies, the suction lumen 204 is used to remove byproducts of wound treatment using the wand 102, such as removal of conductive fluid, molecularly disassociated tissue, and tissue separated from the wound but otherwise still intact. In example operation of a wand for wound care, aggressive aspiration is contemplated to enable removal of larger pieces of tissue not molecularly disassociated. In some cases, the aspiration may be created by an applied pressure between and including 100 millimeters of mercury (mmHg) and 400 mmHg below atmospheric.


Some example wands for dry field procedures are designed and constructed such that the conductive fluid flow exits the source lumen, flows to and/or across the active electrode(s), and then is aspirated into the suction lumen. In the example case of FIG. 2, the conductive plate 210 has a lip portion on the distal end of plate that directs conductive fluid discharged from the source lumen 208 toward the active electrodes. A plasma may be created proximate the active electrodes during periods of time when RF energy is applied to the active electrodes, and then the conductive fluid and ablation byproducts are aspirated into the suction lumen 204. The specification now turns to shortcomings of related-art devices.


The inventors of the present specification have found a shortcoming of related-art devices in the form of variable conductive fluid flow based on orientation of the wand. In the related-art, prior to performing the surgical procedure the conductive fluid flow is manually adjusted, such as by partially clamping the tubing member 116 (e.g., clamping using a hemostat). The adjustment involves setting a flow of conductive fluid out of the source lumen that is substantially aspirated back into the suction lumen (i.e., no or very few drips of conductive fluid when the fluid is flowing out the source lumen). Once the flow of conductive fluid is set, the surgeon performs the procedure; however, an issue arises related to the orientation of the wand, which issue is illustrated with respect to FIGS. 3-5.



FIG. 3 shows an elevation view of a wand 102 with the tubing member 116 coupled to a source of conductive fluid in the form of a saline bag 150. The remaining tubing and cables are not shown so as not to unduly complicate the figure. Consider, for purposes of explanation, that prior to the surgical procedure the wand 102 is held in the orientation shown in FIG. 3, where the handle end 110 and the distal end 108 are at substantially the same elevation. Held in the orientation shown in FIG. 3, a surgeon may adjust the flow of the conductive fluid (e.g., by adjusting the clamping force of hemostat 300) such that there are no or very few drips of conductive fluid from the distal end of the wand 102 (i.e., most if not all the conductive fluid flow is aspirated into the suction lumen). In the orientation shown in FIG. 3, a certain amount of pressure of conductive fluid exists related to the relative elevation between the distal end 108 of the wand and the fluid level in the saline bag 150, as shown by relative height H.


Now consider that during use the surgeon changes the inclination of the distal end 108 in relation to the handle end 110. Stated another way, consider that the elevation of the distal end 108 changes such that the relative height H changes. FIG. 4 shows an elevation view of wand 102 with the tubing member 116 coupled to a source of conductive fluid in the form of a saline bag 150, but where the orientation of the distal end 108 has changed in relation to the handle end 110. In particular, in FIG. 4 the inclination of the wand 102 has changed such that the distal end 108 is lower than the handle end 110 (with the handle end held at a constant elevation), and in so doing the relative height H has increased (considered against the FIG. 3). Given the static restriction to flow illustrated by the hemostat 300, the change in relative height H results in greater conductive fluid flow out of the source lumen at the distal end 108 of wand. The greater conductive fluid flow may result in unintended pooling of conductive fluid, which may have several adverse consequences, such as unintended current paths for the flow of electrical current, and conductive fluid accumulating in undesirable locations like the lungs.


Now consider that during use, the surgeon changes the orientation of the distal end 108 in relation to the handle end 110 as shown in FIG. 5. FIG. 5 shows an elevation view of wand 102 with the tubing member 116 coupled to a source of conductive fluid in the form of a saline bag 150, but where inclination of the wand 102 has changed such that the distal end 108 is higher than the handle end 110, and in so doing the relative height H has decreased. Again, given the static restriction to flow illustrated by the hemostat 300, the change in relative height H (as compared to either FIG. 3 or FIG. 4) results in less conductive fluid flow out of the source lumen at the distal end 108 of wand. Less conductive fluid flow may also result in inadequate wetting of the active electrodes, and thus inefficient ablation or arterial sealing.


In some example systems, the length L of the wand 102 measured from the handle end 110 to the distal end 108 may be six to eight inches. It follows that, even holding the handle end 110 at a constant elevation, the change in elevation of the distal end 108 caused by the change in inclination as between FIGS. 4 and 5 could be significant, on the order of 12-16 inches. Moreover, in use the surgeon may not hold the handle end 110 at a constant elevation relative to the fluid level in the saline bag 150, resulting in further changes in relative height H, each of which results in a change in conductive fluid flow.


In accordance with the various embodiments, the issues associated with changes in conductive fluid flow based on changes in relative height H are addressed, at least in part, by a system and related method which senses changes in orientation of the wand 102, and automatically (i.e., without human involvement at the time of the change) compensates for orientation changes of the wand 102 and/or changes in elevation of the wand 102 (even if orientation remains constant).



FIG. 6 shows an elevation view of wand 102 with the tubing member 116 coupled to a source of conductive fluid in the form of a saline bag 150, but also additional devices to implement in the various example embodiments. In particular, FIG. 6 shows, in partial cutaway, that wand 102 in accordance with example systems comprises an orientation sensor 600. Orientation sensor 600 mechanically couples to the wand (and as shown mechanically couples within an interior volume 602 defined by the wand). Moreover, the orientation sensor 600 communicatively couples to the controller 104, such as by way of conductors 604 (which conductors may reside within the multi-conductor cable 112 of FIG. 1). As the name implies, the orientation sensor 600 senses orientation of the wand 102. The orientation sensor 600 may take many suitable forms, examples of which are discussed more thoroughly below. The example system of FIG. 6 further comprises flow control device 152 which, in the example system, is likewise coupled to the controller 104. In accordance with various embodiments, the flow control device 152 is coupled to the tubing member 116 between the source of conductive fluid (in this example saline bag 150) and the wand 102. The flow control device is designed and constructed to present different restrictions to the flow of conductive fluid based on the orientation of the wand as sensed by the orientation sensor 600.


In accordance with the various embodiments, the surgeon holds the wand in a particular orientation, and sets the flow rate of the conductive fluid such that there are no or very few drips of conductive fluid from the distal end 108 of the wand 102 (i.e., most if not all the conductive fluid flow is aspirated into the suction lumen). Setting the flow may take many forms. In some example systems, the flow may be set or adjusted by the surgeon interfacing with controller 104, such as by pushing buttons 126. In these example systems, interaction with the controller 104 sends a signal to the flow control device to raise or lower the flow allowed to pass through the flow control device. In other cases, the flow may be set by the surgeon interfacing with an interface device 606 on the flow control device 152 itself. For example, the interface device 606 may be a knob that when rotated in a first direction increases the flow of conductive fluid, and when rotated in a second direction decreases the flow the conductive fluid.


Once the initial conductive fluid flow is set (and regardless of the mechanism by which the initial flow is set), the surgeon may begin to use the wand in the electrosurgical procedure, and in using the wand 102 the orientation of the distal end 108 may change. However, the orientation sensor 600 and flow control device 152 (and in some systems the controller 104) work together to control the flow of conductive fluid to reduce the effects of changes in pressure of conductive fluid caused by changes in orientation of the wand 102. For example, if the distal end 108 of the wand 102 is lowered, the relative height H increases which would tend to increase pressure and therefore increase conductive fluid flow; however, sensing the lowering of the distal end 108 of the wand 102 by way of the orientation sensor 600, the system increases flow restriction presented by the flow control device such that conductive fluid flow remains substantially constant. Oppositely, if the distal end 108 of the wand 102 is raised, the relative height H decreases which would tend to decrease pressure and therefore decrease conductive fluid flow; however, sensing the raising of the distal end 108 of the wand 102 by way of the orientation sensor 600, the system decreases flow restriction presented by the flow control device such that conductive fluid flow remains substantially constant.


In yet still other example systems, the control of flow implemented as a function of orientation of the wand may implement orientation specific flow control strategies that differ. For example, if the orientation sensor 600 provides an indication that the distal end 108 is lower than the handle end 110, the system may reduce flow of conductive fluid (as compared to the initial setting) as in the distal-end low orientation gravity may cause increased loss of conductive fluid. Oppositely, if the orientation sensor 600 provides an indication that the distal end 108 is higher than the handle end 110, the system may increase flow of conductive fluid (as compared to the initial setting) as in the distal-end high orientation the effects of gravity may decrease the likelihood of loss of conductive fluid.


Some orientation sensors may be able to sense rotational orientation of the wand 102, and implement rotational-orientation specific flow control strategies. For example, if the system senses that the wand is rotationally-oriented such that source lumen 208 is above the active electrodes and suction lumen, in such an orientation gravity assists the flow toward the suction lumen and thus the system may increase conductive fluid flow. Oppositely, if the system senses that the wand is rotationally-oriented such that source lumen 208 is below the active electrodes and suction lumen 200, in such an orientation gravity works against flow toward the suction lumen and thus the system may decrease conductive fluid flow to reduce the likelihood of loss of conductive fluid. The rotational-orientation changes may be implemented in addition to, or in place of, inclination and/or elevation based control of the conductive fluid flow.


The orientation sensor may take many forms. In some example systems the orientation sensor 600 is an inclinometer that provides and analog or digital value indicative of the relative positions of the handle end 110 and the distal end 108. For example, part number ADIS16209 Digital Inclinometer and Accelerometer available from Analog Device of Englewood, Colo., may be used as inclinometer. However, using an inclinometer as the orientation sensor 600 may not provide the ability to sense elevation changes (with constant inclination) or sense rotational orientation changes. Thus, in other example systems the orientation sensor 600 may be implemented with a digital gyroscope, such as a part number ITG-3050 Integrated Triple-Axis Digital-Output Gyroscope available from InvenSense, Inc. of Sunnyvale, Calif. Using a three-axis gyroscope the system may be able to sense not only changes in inclination of the wand 102, but also sense changes in elevation of the wand 102—that is, sense changes in all three spatial directions. Gyroscopes, whether digital or physical, are slow to “settle” and thus have limitations as to accuracy that reduce with continued measurement time, but where the time frame may span several seconds. Thus, in yet still further embodiments the orientation sensor 600 may be a six-axis gyroscope. “Six-axis” gyroscope is a term of art referring to a device that implements a three-axis gyroscope, as well as a corresponding three-axis accelerometer. By combining the readings of the gyroscope and accelerometer, more accurate measurements of orientation may be provided. Thus, in yet still other systems the orientation sensor 600 may be a six-axis gyroscope, such as a part no. MPU-6000/6050 Six-Axis MEMS MotionTracking Device available from InvenSense, Inc.



FIG. 7 shows, in schematic form, an example flow control device 152 in greater detail. In particular, the flow control device 152 comprises a first connector 700 which is designed and constructed to fluidly couple to a tubing member, such as an upstream portion of tubing member 116 coupled to a saline bag 150 (not shown in FIG. 7). Any suitable connector or connection system may be used, such as a barbed connector, or any of a variety of snap together “quick connectors”. Likewise, the flow control device has a second connector 702 which is designed and constructed to fluidly couple to a tubing member, such as the downstream portion of tubing member 116 coupled to a wand 102 (not shown in FIG. 7). Between the illustrative connectors 700 and 702 resides a valve 704. Valve 704 has a stem 706, and position of the stem 706 (e.g., rotational position, elevational position) controls the restriction to conductive fluid flow presented by the valve 704. Example valve 704 further comprises an automatic valve operator 708 which enables selective positioning of the valve stem 706 based communicative signals received over the conductors 710, in example systems the conductors 710 communicatively coupled to the controller 104. Thus, by sending signals along the conductors 710, the controller 104 may control the restriction to conductive fluid flow presented by the valve 704. In the example system of FIG. 7, the stem 706 position may also be manually adjusted based on manipulation of knob 712 (e.g., when making the initial setting of the conductive fluid flow). In other cases, however, the initial setting of conductive fluid flow is controlled electronically by the controller 104 and valve operator 704. In some example systems, the flow control device 152 may define an outer cover 720 (dashed lines) which defines an internal volume 722 within which the valve 704 resides. However, in other cases the outer cover 720 may be fully or partially omitted.



FIG. 8 shows, in schematic form, a flow control device 152 in accordance with other embodiments. In particular, the flow control device 152 comprises a first connector 800 which is designed and constructed to fluidly couple to a tubing member, such as an upstream portion of tubing member 116 coupled to a saline bag 150 (not shown in FIG. 8). Any suitable connector or connection system may be used, such as a barbed connector, or any of a variety of snap together “quick connectors”. Likewise, the flow control device has a second connector 802 which is designed and constructed to fluidly couple to a tubing member, such as the downstream portion of tubing member 116 coupled to a wand 102 (not shown in FIG. 8). Between the illustrative connectors 800 and 802 resides a valve 804 in the form a pinch valve. That is, the valve 804 provides the selective control of restriction to conductive fluid flow by selectively “pinching” the tubing. Valve 804 has a stem 806, and position the stem 806 relative to the backing member 808 controls the restriction to conductive fluid flow presented by the valve 804. Example valve 804 further comprises an automatic valve operator 810 which enables selective positioning of the valve stem 806 based communicative signals received over the conductors 812, in example systems the conductors 812 communicatively coupled to the controller 104. Thus, by sending signals along the conductors 812, the controller 104 may control the restriction to conductive fluid flow presented by the valve 804. In the example system of FIG. 8, the stem 806 position may also be manually adjusted based on manipulation of feature 814 (e.g., when making the initial setting of the conductive fluid flow). In other cases, however, the initial setting of conductive fluid flow is controlled electronically by the controller 104 and valve operator 810. As before, the flow control device 152 may define an outer cover 820 (dashed lines) which defines an internal volume 822 within which the valve 804 resides. However, in other cases the outer cover 820 may be fully or partially omitted.



FIG. 9 illustrates a controller 104 in accordance with at least some embodiments. In particular, FIG. 9 illustrates the controller 104 coupled to the wand 102, where the wand 102 is shown in simplified form comprising the active electrodes 202/204, the conductive plate 210 acting as a return electrode, electrical leads coupled to the controller 104, and the orientation sensor 600. The controller 104 comprises a processor 900. The processor 900 may be a microcontroller, and therefore the microcontroller may be integral with random access memory (RAM) 902, read-only memory (ROM) 904, digital-to-analog converter (D/A) 906, digital outputs (D/O) 908 and digital inputs (D/I) 910. The processor 900 may further provide one or more externally available peripheral busses, such as a serial bus (e.g., I2C), parallel bus, or other bus and corresponding communication mode. The processor 900 may further be integral with a communication logic 912 to enable the processor 900 to communicate with external devices (such as the orientation sensor 600), as well as internal devices, such as display device 124. Although in some embodiments the controller 104 may implement a microcontroller, in yet other embodiments the processor 900 may be implemented as a standalone central processing unit in combination with individual RAM, ROM, communication, D/A, D/O and D/I devices, as well as communication port hardware for communication to peripheral components.


ROM 904 stores instructions executable by the processor 900. In particular, the ROM 904 may store a software program that implements the various embodiments of controlling flow control device 152 based on orientation of the wand 102 as read from the orientation sensor 600, as well as controlling the voltage generator 816 and interfacing with the user by way of the display device 124 and/or the foot pedal assembly 130 (FIG. 1). The RAM 902 may be the working memory for the processor 900, where data may be temporarily stored and from which instructions may be executed. Processor 900 couples to other devices within the controller 104 by way of the D/A converter 906 (e.g., the voltage generator 916), digital outputs 908 (e.g., the voltage generator 916), digital inputs 910 (i.e., push button switches 126, and the foot pedal assembly 130 (FIG. 1)), and other peripheral devices.


Voltage generator 916 generates selectable alternating current (AC) voltages that are applied to the electrodes of the wand 102. In various embodiments, the voltage generator defines two terminals 924 and 926. The terminals 924 and 926 may couple to active electrodes and return electrodes. As an example, terminal 924 couples to illustrative active electrodes 202 and 204, and terminal 926 couples to the conductive plate 210 acting as return electrode. In accordance with the various embodiments, the voltage generator generates an alternating current (AC) voltage across the terminals 924 and 926. In at least some embodiments the voltage generator 916 is electrically “floated” from the balance of the supply power in the controller 104, and thus the voltage on terminals 924, 926, when measured with respect to the earth ground or common (e.g., common 928) within the controller 104, may or may not show a voltage difference even when the voltage generator 916 is active. A description of one suitable voltage generator 916 can be found in commonly assigned U.S. Pat. Nos. 6,142,992 and 6,235,020, the complete disclosure of both patents are incorporated herein by reference for all purposes.


In some embodiments, the various operational modes of the voltage generator 916 may be controlled by way of digital-to-analog converter 906. That is, for example, the processor 900 may control the output voltage by providing a variable voltage to the voltage generator 916, where the voltage provided is proportional to the voltage generated by the voltage generator 916. In other embodiments, the processor 900 may communicate with the voltage generator by way of one or more digital output signals from the digital output 908 device, or by way of packet based communications using the communication device 912 (connection not specifically shown so as not to unduly complicate FIG. 9).


Still referring to FIG. 9, the orientation sensor 600 communicatively couples to the processor 900 by way of conductors 604 through connector 120. In an example system, male electrical pins 950 and 952 in connector 114 couple to female electrical pins 954 and 956 in connector 120, and thus by plugging connector 114 in to the connector 120, electrical connection is made. Within the controller 104 the communicative connections couple to the processor 900. There are a variety of communicative coupling scenarios possible with respect to processor 900 and orientation sensor 600, which depend in part on the type of orientation sensor used. For example, in some cases the communication from the orientation sensor may be by way of an analog signal, in which case the system would comprise electrical connection to an analog-to-digital input (not specifically shown). In other cases, the communication between the orientation sensor 600 and the processor 900 may be a digital serial communication, in which case the system would comprise electrical connection to the communication logic 912. So as not to unduly complicate the figure, the signals from the orientation sensor are shown only to couple to the processor 900. Regardless of how the processor 900 and orientation sensor 600 are communicatively coupled, by reading the orientation information from the orientation sensor 600 the processor 900, executing a program, may control the restriction to flow presented by the flow control device.


The flow control device 152 (not shown in FIG. 9) communicatively couples to the processor 900 by way of conductors 970 through connector 158. In an example system, male electrical pins 972 and 974 in connector 156 couple to female electrical pins 976 and 978 in connector 158, and thus by plugging connector 156 in to the connector 158, electrical connection is made. Within the controller 104 the communicative connections couple to the processor 900. There are a variety of communicative coupling scenarios possible with respect to processor 900 and flow control device 152, which depend in part on the type of flow control device 152. For example, in some cases the communication from the processor 900 may be by way of an analog signal, in which case the system would comprise electrical connection to the digital-to-analog module 906. In other cases, the communication between the processor 900 and the flow control device 152 may be a digital serial communication, in which case the system would comprise electrical connection to the communication logic 912. So as not to unduly complicate the figure, the signals from the flow control device are shown only to couple to the processor 900. Nevertheless, by sending signals to the flow control device the processor 900, executing a program, may control the restriction to flow presented by the flow control device.


The example systems discussed to this point have assumed that the controller 104 is directly responsible for reading orientation information from the orientation sensor 600 and commanding the flow control device 152 to change the restriction to the flow of conductive fluid. However, in yet still other example embodiment the adjustments to conductive fluid flow may be controlled logically outside the controller 104. FIG. 10 shows an elevation view of a system in accordance with yet still further embodiments. In particular, in the example system of FIG. 10 the flow control device 1000 is a standalone device that is directly communicatively coupled to the orientation sensor 600 by way multi-conductor cable 1002. The electrical coupling of the wand 102 to the controller 104 would still be present, but is not shown in FIG. 10 so as not to unduly complicate the figure. Moreover, the wand 102 will likewise still couple to a source of vacuum, but again such is not shown so as not to unduly complicate the figure.


Operation of the example system of FIG. 10 is similar to the previous embodiments. When a change in orientation (e.g., inclination, elevation, rotational-orientation) of the wand 102 is sensed, the flow control device 1000 may change the restriction to flow of conductive fluid to keep the flow substantially the same in spite of the orientation change, or to implement a predetermined flow strategy based on the orientation. All the example methods discussed above (and below) are applicable to the example system of FIG. 10.



FIG. 11 shows a schematic diagram of flow control device 1000 in accordance with example systems. In particular, flow control device 1000 comprises a valve 1100 of similar design, construction, and operation as discussed with respect to FIG. 8. For that reason, the operation of the valve 1100 will not be discussed again here in detail. While a “pinch” type valve is shown, a valve such as shown in FIG. 7 may be equivalently used. Similarly, flow control device 1000 comprises connectors 1102 and 1104 associated with the tubing, where the connectors are similar to those discussed in FIGS. 7 and 8, and so will not be discussed again here. However, the flow control device 1000 of FIG. 11 also comprises a computer system comprising a processor 1106 coupled to a memory 1108 (e.g., RAM memory) and also coupled to a long term storage device 1110 (e.g., ROM, battery backed RAM, flash memory). The long term storage device 1110 may store programs that are copied to the memory 1108 and executed by the processor 1106, including programs to implement the various embodiments disclosed herein. Also coupled to the processor 1106 in an input/output (I/O) device 1112, which I/O device 1112 enables the processor to be communicatively coupled to the valve operator of valve 1100, as well as to be communicatively coupled to the orientation sensor 600 in the wand 102. The precise nature of the I/O device 1112 depends on the communication system by which the valve operator and orientation sensor communicate (e.g., analog signals, parallel digital signals, serial digital communications). It is noted that the different I/O devices may be used as between the valve operator and the orientation sensor.


The example flow control device 1000 further comprises a power supply 1120 which may supply power to all the devices of the flow control device that need power. The electrical connections between the power supply 1120 and the remaining components of the flow control device 1000 are not shown so as not to unduly complicate the figure. In some example systems, the power supply 1120 is a battery or battery system. In other cases, the power supply 1120 takes power from a standard wall socket, and coverts the energy into a correct format for the various devices of the flow control device 1000 (e.g, converts 120 VAC from the wall socket to 3.3 VDC for the electronic components, and 12 VDC for valve operator 1150). In the example system standalone system, operational power for the orientation sensor 600 may be provided from the flow control device 1000.



FIG. 12 shows a method in accordance with at least some embodiments, portions of which may be implemented by software executing on a processor. In particular, the method starts (block 1200) and comprises: flowing conductive fluid from a source lumen to a suction lumen of an electrosurgical wand, the flowing with the electrosurgical wand in a first orientation (block 1202); sensing a change in orientation of the electrosurgical wand to a second orientation different than the first orientation (block 1204); and changing a control parameter associated with the conductive fluid flow, the changing responsive to the change in orientation of the electrosurgical wand (block 1206). Thereafter, the methods ends (block 1208), likely to be immediately repeated when orientation of the wand again changes.


From the description provided herein, those skilled in the art are readily able to combine software created as described with appropriate general-purpose or special-purpose computer hardware to create a computer system and/or computer sub-components in accordance with the various embodiments, to create a computer system and/or computer sub-components for carrying out the methods of the various embodiments and/or to create a non-transitory computer-readable medium (i.e., not a carrier wave) that stores a software program to implement the method aspects of the various embodiments.


While preferred embodiments of this disclosure have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching herein. The embodiments described herein are exemplary only and are not limiting. Because many varying and different embodiments may be made within the scope of the present inventive concept, including equivalent structures, materials, or methods hereafter though of, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirements of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.

Claims
  • 1. A method comprising: flowing an electrically conductive fluid from at least one source lumen of an electrosurgical wand, the flowing with the electrosurgical wand in a first orientation;sensing a change in orientation of the electrosurgical wand to a second orientation different than the first orientation, the sensing by a computer system; andchanging a control parameter associated with the electrically conductive fluid flow, the changing configured to compensate for changes in electrically conductive fluid flow from the at least one source lumen due to the change in orientation of the electrosurgical wand, and changing the control parameter by the computer system;wherein both the step of flowing and the step of changing a control parameter associated with electrically conductive fluid flow define a flow rate configured to create plasma adjacent an active electrode of the electrosurgical wand while RF energy is supplied to the active electrode.
  • 2. The method of claim 1 wherein sensing the change in orientation further comprises sensing using an inclinometer mechanically coupled to the electrosurgical wand, and the inclinometer communicatively coupled to the computer system.
  • 3. The method of claim 1 wherein sensing the change in orientation further comprises sensing using a gyroscope mechanically coupled to the electrosurgical wand, and the gyroscope communicatively coupled to the computer system.
  • 4. The method of claim 1 wherein sensing the change in orientation further comprises sensing using a three-axis gyroscope mechanically coupled to the electrosurgical wand, and the gyroscope communicatively coupled to the computer system.
  • 5. The method of claim 1 wherein sensing the change in orientation further comprises sensing using a six-axis gyroscope mechanically coupled to the electrosurgical wand, and the gyroscope communicatively coupled to the computer system.
  • 6. The method of claim 1 wherein changing the control parameter further comprises changing an amount of flow restriction within the flow of conductive fluid, the flow restriction between a source of the conductive fluid and the at least one source lumen.
  • 7. The method of claim 1 wherein changing the control parameter further comprises changing a position of a valve stem of a valve by the computer system, the valve coupled within tubing between a source of conductive fluid and the at least one source lumen of the electrosurgical wand.
  • 8. The method of claim 1 wherein changing the control parameter further comprises changing an amount of pinch applied to a portion of tubing disposed between a source of the conductive fluids and the at least one source lumen.
  • 9. The method of claim 1, wherein the flow rate is configured to control tissue coagulation adjacent the active electrode during periods of time when RF energy is supplied to the active electrode.
  • 10. The method of claim 1, wherein the flow rate is configured to limit fluid pooling away from the active electrode, so as to limit unintended electrosurgical tissue treatment during periods of time when RF energy is supplied to the active electrode.
  • 11. The method of claim 1 wherein the flow rate is configured to provide adequate wetting of the active electrode, so as to limit unintended heating of the active electrode during periods of time when RF energy is supplied to the active electrode.
  • 12. A method comprising: flowing conductive fluid through at least one lumen on a distal end of an electrosurgical wand, while the electrosurgical wand is in a first orientation;sensing a change in orientation of the electrosurgical wand to a second orientation different than the first orientation, the sensing by an orientation sensor coupled to a handle of the wand; andchanging a control parameter associated with the conductive fluid flow, the changing configured so as to compensate for a change in flow of the conductive fluid due to the change in orientation of the electrosurgical wand, and the changing the control parameter by a computer system in communication with the orientation sensor;wherein both the step of flowing and the step of changing a control parameter associated with conductive fluid flow define a flow rate, configured to form and maintain a vapor layer at an active electrode of the electrosurgical wand during periods of time when RF energy is supplied to the active electrode.
  • 13. The method of claim 12 wherein the orientation sensor is an inclinometer.
  • 14. The method of claim 12 wherein the orientation sensor is a gyroscope.
  • 15. The method of claim 12 wherein the orientation sensor is a three-axis gyroscope.
  • 16. The method of claim 12 wherein the orientation sensor is a six-axis gyroscope.
  • 17. The method of claim 12 wherein changing the control parameter further comprises changing an amount of flow restriction within the flow of conductive fluid, the flow restriction between a source of the conductive fluid and the at least one lumen.
  • 18. The method of claim 12 wherein changing the control parameter further comprises changing a position of a valve stem of a valve by the computer system, the valve coupled within tubing between a source of conductive fluid and the at least one lumen of the electrosurgical wand.
  • 19. The method of claim 12 wherein changing the control parameter further comprises changing an amount of pinch applied to a portion of tubing disposed between a source of the conductive fluids and the at least one lumen.
  • 20. A method comprising: orienting an electrosurgical wand so that a wand handle end and a wand distal end are at substantially the same elevation;flowing conductive fluid from a source lumen disposed adjacent the wand distal end;adjusting a flowrate of the conductive fluid to a desired flowrate;sensing a change in elevation between the handle end and the distal end, the sensing by an orientation sensor associated with the wand and wherein the change in elevation causes a change in the flowrate away from the desired flowrate; andchanging a control parameter associated with the conductive fluid flow so as to compensate for the change in flowrate due to the change in elevation between the handle end and the distal end and return the flowrate closer to the desired flowratewherein both the step of flowing and the step of changing a control parameter associated with conductive fluid flow define a flow rate, configured to form and maintain a vapor layer at an active electrode of the electrosurgical wand during periods of time when RF energy is supplied to the active electrode.
  • 21. The method of claim 20 wherein the orientation sensor is in communication with a flow control device and wherein changing the control parameter changes the restriction of the flow to the source lumen.
  • 22. The method of claim 21 wherein when the orientation sensor senses that the handle end is lower relative to the distal end, the fluid control device decreases the restriction to the fluid flow.
  • 23. The method of claim 21 wherein when the orientation sensor senses that the handle end is higher relative to the distal end, the fluid control device further restricts the fluid flow.
US Referenced Citations (562)
Number Name Date Kind
2050904 Trice Apr 1936 A
2056377 Wappler Oct 1939 A
2611365 Rubens Sep 1952 A
3434476 Shaw et al. Mar 1969 A
3633425 Sanford Jan 1972 A
3707149 Hao et al. Dec 1972 A
3718617 Royal Feb 1973 A
3815604 O'Malley et al. Jun 1974 A
3828780 Morrison, Jr. et al. Aug 1974 A
3901242 Storz Aug 1975 A
3920021 Hiltebrandt Nov 1975 A
3939839 Curtiss Feb 1976 A
3963030 Newton Jun 1976 A
3964487 Judson Jun 1976 A
3970088 Morrison Jul 1976 A
4033351 Hetzel Jul 1977 A
4040426 Morrison, Jr. Aug 1977 A
4043342 Morrison, Jr. Aug 1977 A
4074718 Morrison, Jr. Feb 1978 A
4092986 Schneiderman Jun 1978 A
D249549 Pike Sep 1978 S
4114623 Meinke et al. Sep 1978 A
4116198 Roos Sep 1978 A
4181131 Ogiu Jan 1980 A
4184492 Meinke et al. Jan 1980 A
4202337 Hren et al. May 1980 A
4228800 Degler, Jr. et al. Oct 1980 A
4232676 Herczog Nov 1980 A
4240441 Khalil Dec 1980 A
4248231 Herczog et al. Feb 1981 A
4301801 Schneiderman Nov 1981 A
4326529 Doss Apr 1982 A
4346715 Gammell Aug 1982 A
4363324 Kusserow Dec 1982 A
4378801 Oosten Apr 1983 A
4381007 Doss Apr 1983 A
4418692 Guay Dec 1983 A
4474179 Koch Oct 1984 A
4476862 Pao Oct 1984 A
4509532 DeVries Apr 1985 A
4520818 Mickiewicz Jun 1985 A
4532924 Auth et al. Aug 1985 A
4548207 Reimels Oct 1985 A
4567890 Ohta et al. Feb 1986 A
4572206 Geddes et al. Feb 1986 A
4580557 Hertzmann Apr 1986 A
4587975 Salo et al. May 1986 A
4590934 Malis et al. May 1986 A
4593691 Lindstrom et al. Jun 1986 A
4658817 Hardy Apr 1987 A
4660571 Hess et al. Apr 1987 A
4674499 Pao Jun 1987 A
4682596 Bales et al. Jul 1987 A
4706667 Roos Nov 1987 A
4709698 Johnston et al. Dec 1987 A
4727874 Bowers et al. Mar 1988 A
4750902 Wuchinich et al. Jun 1988 A
4765331 Petruzzi et al. Aug 1988 A
4785823 Eggers et al. Nov 1988 A
4805616 Pao Feb 1989 A
4823791 D'Amelio et al. Apr 1989 A
4832048 Cohen May 1989 A
4846179 O'Connor Jul 1989 A
4860752 Turner Aug 1989 A
4898169 Norman et al. Feb 1990 A
4907589 Cosman Mar 1990 A
4920978 Colvin May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936301 Rexroth et al. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4955377 Lennox et al. Sep 1990 A
4966597 Cosman Oct 1990 A
4967765 Turner et al. Nov 1990 A
4976711 Parins et al. Dec 1990 A
4979948 Geddes et al. Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5007908 Rydell Apr 1991 A
5009656 Reimels Apr 1991 A
5026387 Thomas Jun 1991 A
5035696 Rydell Jul 1991 A
5047026 Rydell Sep 1991 A
5047027 Rydell Sep 1991 A
5057105 Malone et al. Oct 1991 A
5057106 Kasevich et al. Oct 1991 A
5078717 Parins et al. Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins et al. Jan 1992 A
5084044 Quint Jan 1992 A
5085659 Rydell Feb 1992 A
5086401 Glassman et al. Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5092339 Geddes et al. Mar 1992 A
5098431 Rydell Mar 1992 A
5099840 Goble Mar 1992 A
5102410 Dressel Apr 1992 A
5108391 Flachenecker et al. Apr 1992 A
RE33925 Bales et al. May 1992 E
5112330 Nishigaki et al. May 1992 A
5122138 Manwaring Jun 1992 A
5125928 Parins et al. Jun 1992 A
5156151 Imran Oct 1992 A
5167659 Ohtomo et al. Dec 1992 A
5171311 Rydell et al. Dec 1992 A
5174304 Latina et al. Dec 1992 A
5178620 Eggers et al. Jan 1993 A
5183338 Wickersheim et al. Feb 1993 A
5190517 Zieve et al. Mar 1993 A
5192280 Parins Mar 1993 A
5195959 Smith Mar 1993 A
5197466 Marchosky et al. Mar 1993 A
5197963 Parins Mar 1993 A
5207675 Canady May 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217459 Kamerling Jun 1993 A
5249585 Turner et al. Oct 1993 A
5255980 Thomas et al. Oct 1993 A
5261410 Alfano et al. Nov 1993 A
5267994 Gentelia et al. Dec 1993 A
5267997 Farin et al. Dec 1993 A
5273524 Fox et al. Dec 1993 A
5277201 Stern Jan 1994 A
5281216 Klicek Jan 1994 A
5281218 Imran Jan 1994 A
5282799 Rydell Feb 1994 A
5290282 Casscells Mar 1994 A
5300069 Hunsberger et al. Apr 1994 A
5306238 Fleenor Apr 1994 A
5312400 Bales et al. May 1994 A
5314406 Arias et al. May 1994 A
5318563 Malis et al. Jun 1994 A
5324254 Phillips Jun 1994 A
5330470 Hagen Jul 1994 A
5334140 Phillips Aug 1994 A
5334183 Wuchinich Aug 1994 A
5334193 Nardella Aug 1994 A
5336172 Bales et al. Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5336443 Odashima Aug 1994 A
5342357 Nardella Aug 1994 A
5348026 Davidson Sep 1994 A
5348554 Imran et al. Sep 1994 A
5354291 Bales et al. Oct 1994 A
5366443 Eggers et al. Nov 1994 A
5370675 Edwards et al. Dec 1994 A
5374261 Yoon Dec 1994 A
5375588 Yoon Dec 1994 A
5380277 Phillips Jan 1995 A
5380316 Aita Jan 1995 A
5383874 Jackson et al. Jan 1995 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5389096 Aita Feb 1995 A
5395312 Desai Mar 1995 A
5400267 Denen et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403311 Abele et al. Apr 1995 A
5417687 Nardella et al. May 1995 A
5419767 Eggers et al. May 1995 A
5423810 Goble et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5436566 Thompson et al. Jul 1995 A
5437662 Nardella Aug 1995 A
5438302 Goble Aug 1995 A
5441499 Fritzsch Aug 1995 A
5449356 Walbrink et al. Sep 1995 A
5451224 Goble et al. Sep 1995 A
5454809 Janssen Oct 1995 A
5458596 Lax et al. Oct 1995 A
5458597 Edwards et al. Oct 1995 A
5472443 Cordis et al. Dec 1995 A
5472444 Huebner et al. Dec 1995 A
5486161 Lax et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5496314 Eggers Mar 1996 A
5496317 Goble et al. Mar 1996 A
5505730 Edwards Apr 1996 A
5507743 Edwards et al. Apr 1996 A
5514130 Baker May 1996 A
5540683 Ichikawa et al. Jul 1996 A
5542915 Edwards et al. Aug 1996 A
5549598 O'Donnell, Jr. Aug 1996 A
5554152 Aita Sep 1996 A
5556397 Long et al. Sep 1996 A
5562703 Desai Oct 1996 A
5569242 Lax et al. Oct 1996 A
5571100 Goble et al. Nov 1996 A
5573533 Strul Nov 1996 A
5584872 LaFontaine et al. Dec 1996 A
5588960 Edwards et al. Dec 1996 A
5599350 Schulze et al. Feb 1997 A
5609151 Mulier et al. Mar 1997 A
5609573 Sandock Mar 1997 A
5633578 Eggers et al. May 1997 A
5634921 Hood et al. Jun 1997 A
5643304 Schechter et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5658278 Imran et al. Aug 1997 A
5660567 Nierlich et al. Aug 1997 A
5662680 Desai Sep 1997 A
5676693 LaFontaine et al. Oct 1997 A
5681282 Eggers et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5715817 Stevens-Wright et al. Feb 1998 A
5722975 Edwards et al. Mar 1998 A
5725524 Mulier et al. Mar 1998 A
5749869 Lindenmeier et al. May 1998 A
5749871 Hood et al. May 1998 A
5749914 Janssen May 1998 A
5755753 Knowlton May 1998 A
5766153 Eggers et al. Jun 1998 A
5769847 Panescu et al. Jun 1998 A
5785705 Baker Jul 1998 A
5786578 Christy et al. Jul 1998 A
5800429 Edwards Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5836875 Webster, Jr. Nov 1998 A
5836897 Sakurai et al. Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5860951 Eggers Jan 1999 A
5860974 Abele Jan 1999 A
5860975 Goble et al. Jan 1999 A
5871469 Eggers et al. Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5873877 McGaffigan et al. Feb 1999 A
5874039 Edelson Feb 1999 A
5885277 Korth Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891134 Goble et al. Apr 1999 A
5897553 Mulier Apr 1999 A
5902272 Eggers et al. May 1999 A
5944715 Goble et al. Aug 1999 A
5954716 Sharkey et al. Sep 1999 A
5964786 Ochs et al. Oct 1999 A
6004319 Goble et al. Dec 1999 A
6013076 Goble et al. Jan 2000 A
6015406 Goble et al. Jan 2000 A
6024733 Eggers et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6039734 Goble et al. Mar 2000 A
6047700 Eggers et al. Apr 2000 A
6056746 Goble et al. May 2000 A
6063079 Hovda et al. May 2000 A
6066134 Eggers et al. May 2000 A
6066489 Fields et al. May 2000 A
6068628 Fanton et al. May 2000 A
6074386 Goble et al. Jun 2000 A
6086585 Hovda et al. Jul 2000 A
6090106 Goble et al. Jul 2000 A
6090107 Borgmeier et al. Jul 2000 A
6093186 Goble et al. Jul 2000 A
6102046 Weinstein et al. Aug 2000 A
6103298 Edelson et al. Aug 2000 A
6105581 Eggers et al. Aug 2000 A
6109268 Thapliyal et al. Aug 2000 A
6117109 Eggers et al. Sep 2000 A
6126682 Sharkey et al. Oct 2000 A
6135999 Fanton et al. Oct 2000 A
6142992 Cheng et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6156334 Meyer-ingold et al. Dec 2000 A
6159194 Eggers et al. Dec 2000 A
6159208 Hovda et al. Dec 2000 A
6162217 Kannenberg et al. Dec 2000 A
6168593 Sharkey et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6179836 Eggers et al. Jan 2001 B1
6183469 Thapliyal et al. Feb 2001 B1
6190381 Olsen et al. Feb 2001 B1
6197021 Panescu et al. Mar 2001 B1
6203542 Ellsberry et al. Mar 2001 B1
6210402 Olsen et al. Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6217574 Webster Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6228078 Eggers May 2001 B1
6228081 Goble May 2001 B1
6234178 Goble et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6238393 Mulier et al. May 2001 B1
6241723 Heim et al. Jun 2001 B1
6249706 Sobota et al. Jun 2001 B1
6254600 Willink et al. Jul 2001 B1
6258087 Edwards et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261311 Sharkey et al. Jul 2001 B1
6264652 Eggers et al. Jul 2001 B1
6270460 McCartan et al. Aug 2001 B1
6277112 Underwood et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6283961 Underwood et al. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6308089 von der Ruhr et al. Oct 2001 B1
6309387 Eggers et al. Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6319007 Livaditis Nov 2001 B1
6322549 Eggers et al. Nov 2001 B1
6346104 Daly et al. Feb 2002 B2
6346107 Cucin Feb 2002 B1
6355032 Hovda et al. Mar 2002 B1
6363937 Hovda et al. Apr 2002 B1
6364877 Goble et al. Apr 2002 B1
6379350 Sharkey et al. Apr 2002 B1
6379351 Thapliyal et al. Apr 2002 B1
6391025 Weinstein et al. May 2002 B1
6409722 Hoey et al. Jun 2002 B1
6416507 Eggers et al. Jul 2002 B1
6416508 Eggers et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6425912 Knowlton Jul 2002 B1
6432103 Ellsberry et al. Aug 2002 B1
6440129 Simpson Aug 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6482201 Olsen et al. Nov 2002 B1
6500173 Underwood et al. Dec 2002 B2
6514248 Eggers et al. Feb 2003 B1
6514250 Jahns et al. Feb 2003 B1
6517498 Burbank et al. Feb 2003 B1
6530922 Cosman Mar 2003 B2
6558382 Jahns et al. May 2003 B2
6565560 Goble et al. May 2003 B1
6578579 Burnside Jun 2003 B2
6589237 Woloszko et al. Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6620156 Garito et al. Sep 2003 B1
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6635034 Cosmescu Oct 2003 B1
6640128 Vilsmeier et al. Oct 2003 B2
6656177 Truckai et al. Dec 2003 B2
6663554 Babaev Dec 2003 B2
6663627 Francischelli et al. Dec 2003 B2
6702810 McClurken et al. Mar 2004 B2
6730080 Harano et al. May 2004 B2
6746447 Davison et al. Jun 2004 B2
6749604 Eggers et al. Jun 2004 B1
6749608 Garito et al. Jun 2004 B2
D493530 Reschke Jul 2004 S
6770071 Woloszko et al. Aug 2004 B2
6780178 Palanker et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6780184 Tanrisever Aug 2004 B2
6802842 Ellman et al. Oct 2004 B2
6805130 Tasto et al. Oct 2004 B2
6830558 Flaherty et al. Dec 2004 B2
6837887 Woloszko et al. Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6855143 Davison et al. Feb 2005 B2
6864686 Novak et al. Mar 2005 B2
6866671 Tierney et al. Mar 2005 B2
6872183 Sampson et al. Mar 2005 B2
6878149 Gatto Apr 2005 B2
6890307 Kokate et al. May 2005 B2
6892086 Russell May 2005 B2
6911027 Edwards et al. Jun 2005 B1
6920883 Bessette et al. Jul 2005 B2
6921398 Carmel et al. Jul 2005 B2
6929640 Underwood et al. Aug 2005 B1
6949096 Davison et al. Sep 2005 B2
6953461 McClurken et al. Oct 2005 B2
6960204 Eggers et al. Nov 2005 B2
6974453 Woloszko et al. Dec 2005 B2
6979328 Baerveldt et al. Dec 2005 B2
6979601 Marr et al. Dec 2005 B2
6984231 Goble et al. Jan 2006 B2
6986770 Hood Jan 2006 B2
6991631 Woloszko et al. Jan 2006 B2
7001382 Gallo Feb 2006 B2
7004941 Tvinnereim et al. Feb 2006 B2
7010353 Gan et al. Mar 2006 B2
7041102 Truckai et al. May 2006 B2
7070596 Woloszko et al. Jul 2006 B1
7090672 Underwood et al. Aug 2006 B2
7094215 Davison et al. Aug 2006 B2
7094231 Ellman et al. Aug 2006 B1
7104986 Hovda et al. Sep 2006 B2
7115139 McClurken et al. Oct 2006 B2
7131969 Hovda et al. Nov 2006 B1
7169143 Eggers et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7192428 Eggers et al. Mar 2007 B2
7201750 Eggers et al. Apr 2007 B1
7217268 Eggers et al. May 2007 B2
7223265 Keppel May 2007 B2
7241293 Davison Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7270658 Woloszko et al. Sep 2007 B2
7270659 Ricart et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7271363 Lee et al. Sep 2007 B2
7276061 Schaer et al. Oct 2007 B2
7276063 Davison et al. Oct 2007 B2
7278994 Goble Oct 2007 B2
7282048 Goble et al. Oct 2007 B2
7297143 Woloszko et al. Nov 2007 B2
7297145 Woloszko et al. Nov 2007 B2
7318823 Sharps et al. Jan 2008 B2
7331956 Hovda et al. Feb 2008 B2
7335199 Goble et al. Feb 2008 B2
RE40156 Sharps et al. Mar 2008 E
7338489 Kadoch Mar 2008 B2
7344532 Goble et al. Mar 2008 B2
7357798 Sharps et al. Apr 2008 B2
7387625 Hovda et al. Jun 2008 B2
7419488 Ciarrocca et al. Sep 2008 B2
7429260 Underwood et al. Sep 2008 B2
7429262 Woloszko et al. Sep 2008 B2
7435247 Woloszko et al. Oct 2008 B2
7442191 Hovda et al. Oct 2008 B2
7445618 Eggers et al. Nov 2008 B2
7449021 Underwood et al. Nov 2008 B2
7462178 Woloszko et al. Dec 2008 B2
7468059 Eggers et al. Dec 2008 B2
7491200 Underwood et al. Feb 2009 B2
7507236 Eggers et al. Mar 2009 B2
7527624 Dubnack et al. May 2009 B2
7572251 Davison et al. Aug 2009 B1
7632267 Dahla Dec 2009 B2
7678069 Baker et al. Mar 2010 B1
7691101 Davison et al. Apr 2010 B2
7699830 Martin Apr 2010 B2
7704249 Woloszko et al. Apr 2010 B2
7708733 Sanders et al. May 2010 B2
7722601 Wham et al. May 2010 B2
7785322 Penny et al. Aug 2010 B2
7824398 Woloszko et al. Nov 2010 B2
7862560 Marion Jan 2011 B2
7879034 Woloszko et al. Feb 2011 B2
7887538 Bleich et al. Feb 2011 B2
7892230 Woloszko et al. Feb 2011 B2
7901403 Woloszko et al. Mar 2011 B2
7985072 Belikov et al. Jul 2011 B2
7988689 Woloszko et al. Aug 2011 B2
8012153 Woloszko et al. Sep 2011 B2
8114071 Woloszko et al. Feb 2012 B2
D658760 Cox et al. May 2012 S
8192424 Woloszko Jun 2012 B2
8257350 Marion Sep 2012 B2
8303583 Hosier et al. Nov 2012 B2
8372067 Woloszko et al. Feb 2013 B2
8568405 Cox et al. Oct 2013 B2
8574187 Marion Nov 2013 B2
8685018 Cox et al. Apr 2014 B2
8747399 Woloszko et al. Jun 2014 B2
8870866 Woloszko Oct 2014 B2
20020029036 Goble et al. Mar 2002 A1
20020042612 Hood et al. Apr 2002 A1
20020052600 Davison May 2002 A1
20020151882 Marko et al. Oct 2002 A1
20020183739 Long Dec 2002 A1
20030013986 Saadat Jan 2003 A1
20030014045 Russell Jan 2003 A1
20030014047 Woloszko et al. Jan 2003 A1
20030088245 Woloszko et al. May 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030167035 Flaherty et al. Sep 2003 A1
20030171743 Tasto et al. Sep 2003 A1
20030181903 Hood et al. Sep 2003 A1
20030208196 Stone Nov 2003 A1
20030212395 Woloszko Nov 2003 A1
20030212396 Eggers et al. Nov 2003 A1
20030216725 Woloszko et al. Nov 2003 A1
20030216726 Eggers et al. Nov 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030232048 Yang et al. Dec 2003 A1
20040030330 Brassell et al. Feb 2004 A1
20040058153 Ren et al. Mar 2004 A1
20040092925 Rizoiu et al. May 2004 A1
20040102044 Mao et al. May 2004 A1
20040116922 Hovda et al. Jun 2004 A1
20040127893 Hovda Jul 2004 A1
20040186418 Karashima Sep 2004 A1
20040215183 Hoey et al. Oct 2004 A1
20040230190 Dahla et al. Nov 2004 A1
20050004634 Ricart et al. Jan 2005 A1
20050010205 Hovda et al. Jan 2005 A1
20050015085 McClurken et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050197657 Goth et al. Sep 2005 A1
20050212870 Chiao Sep 2005 A1
20050245923 Christopherson et al. Nov 2005 A1
20050261754 Woloszko et al. Nov 2005 A1
20050273091 Booth et al. Dec 2005 A1
20060036237 Davison et al. Feb 2006 A1
20060095031 Ormsby May 2006 A1
20060097615 Tsakalakos et al. May 2006 A1
20060161148 Behnke Jul 2006 A1
20060189971 Tasto et al. Aug 2006 A1
20060253117 Hovda et al. Nov 2006 A1
20060259025 Dahla Nov 2006 A1
20060287650 Cao Dec 2006 A1
20070106288 Woloszko et al. May 2007 A1
20070149966 Dahla et al. Jun 2007 A1
20070161981 Sanders et al. Jul 2007 A1
20070179491 Kratoska et al. Aug 2007 A1
20070179495 Mitchell et al. Aug 2007 A1
20080004615 Woloszko et al. Jan 2008 A1
20080077128 Woloszko et al. Mar 2008 A1
20080097476 Peh et al. Apr 2008 A1
20080138761 Pond Jun 2008 A1
20080140069 Filloux et al. Jun 2008 A1
20080154255 Panos et al. Jun 2008 A1
20080167645 Woloszko Jul 2008 A1
20080234674 McClurken et al. Sep 2008 A1
20080243116 Anderson Oct 2008 A1
20080261368 Ramin et al. Oct 2008 A1
20080300590 Horne et al. Dec 2008 A1
20090209956 Marion Aug 2009 A1
20090209958 Davison et al. Aug 2009 A1
20090222001 Greeley et al. Sep 2009 A1
20100042101 Inagaki et al. Feb 2010 A1
20100121317 Lorang et al. May 2010 A1
20100152726 Cadouri et al. Jun 2010 A1
20100228246 Marion Sep 2010 A1
20100292689 Davison et al. Nov 2010 A1
20100318083 Davison et al. Dec 2010 A1
20100331883 Schmitz et al. Dec 2010 A1
20110137308 Woloszko et al. Jun 2011 A1
20110208177 Brannan Aug 2011 A1
20110245826 Woloszko et al. Oct 2011 A1
20110270256 Nelson et al. Nov 2011 A1
20110319887 Keppel Dec 2011 A1
20120083782 Stalder et al. Apr 2012 A1
20120095453 Cox et al. Apr 2012 A1
20120095454 Cox et al. Apr 2012 A1
20120109123 Woloszko et al. May 2012 A1
20120190969 Kameli Jul 2012 A1
20120191089 Gonzalez Jul 2012 A1
20120196251 Taft et al. Aug 2012 A1
20120197344 Taft et al. Aug 2012 A1
20120215221 Woloszko Aug 2012 A1
20120296328 Marion Nov 2012 A1
20130116680 Woloszko May 2013 A1
20140018798 Cox et al. Jan 2014 A1
20140025065 Marion Jan 2014 A1
20140135760 Cadouri et al. May 2014 A1
20140155882 Cox et al. Jun 2014 A1
20140236141 Woloszko et al. Aug 2014 A1
20140257277 Woloszko et al. Sep 2014 A1
20140257278 Woloszko et al. Sep 2014 A1
20140257279 Woloszko et al. Sep 2014 A1
20140276725 Cox Sep 2014 A1
20150032101 Woloszko et al. Jan 2015 A1
Foreign Referenced Citations (78)
Number Date Country
3119735 Jan 1983 DE
3930451 Mar 1991 DE
69635311 Apr 2007 DE
10201003288 Sep 2014 DE
423757 Mar 1996 EP
0703461 Mar 1996 EP
0740926 Nov 1996 EP
0754437 Jan 1997 EP
0694290 Nov 2000 EP
1334699 Aug 2003 EP
1428480 Jun 2004 EP
1707147 Oct 2006 EP
2055254 Feb 2015 EP
2313949 Jan 1977 FR
467502 Jun 1937 GB
2160102 Dec 1985 GB
2299216 Sep 1996 GB
2 308 979 Jul 1997 GB
2 308 980 Jul 1997 GB
2 308 981 Jul 1997 GB
2 327 350 Jan 1999 GB
2 327 351 Jan 1999 GB
2 327 352 Jan 1999 GB
2333455 Jul 1999 GB
2406793 Apr 2005 GB
2514442 Nov 2014 GB
57-57802 Apr 1982 JP
57-117843 Jul 1982 JP
9003152 Apr 1990 WO
9007303 Jul 1990 WO
9221278 Dec 1992 WO
9313816 Jul 1993 WO
9320747 Oct 1993 WO
9404220 Mar 1994 WO
9408654 Apr 1994 WO
9410921 May 1994 WO
9426228 Nov 1994 WO
9534259 Dec 1995 WO
9600040 Jan 1996 WO
9600042 Jan 1996 WO
9639086 Dec 1996 WO
9700646 Jan 1997 WO
9700647 Jan 1997 WO
9718768 May 1997 WO
9724073 Jul 1997 WO
9724074 Jul 1997 WO
9724993 Jul 1997 WO
9724994 Jul 1997 WO
9743971 Nov 1997 WO
9748345 Dec 1997 WO
9748346 Dec 1997 WO
9807468 Feb 1998 WO
9826724 Jun 1998 WO
9827879 Jul 1998 WO
9827880 Jul 1998 WO
9856324 Dec 1998 WO
9920213 Apr 1999 WO
9951155 Oct 1999 WO
9951158 Oct 1999 WO
9956648 Nov 1999 WO
0000098 Jan 2000 WO
0009053 Feb 2000 WO
0062685 Oct 2000 WO
0124720 Apr 2001 WO
0187154 May 2001 WO
0195819 Dec 2001 WO
0236028 May 2002 WO
02102255 Dec 2002 WO
03024305 Mar 2003 WO
03092477 Nov 2003 WO
2004026150 Apr 2004 WO
2004071278 Aug 2004 WO
2005125287 Dec 2005 WO
2007006000 Jan 2007 WO
2007056729 May 2007 WO
2010052717 May 2010 WO
2012050636 Apr 2012 WO
2012050637 Apr 2012 WO
Non-Patent Literature Citations (115)
Entry
Barry et al., “The Effect of Radiofrequency-generated Thermal Energy on the Mechanical and Histologic Characteristics of the Arterial Wall in Vivo: Implications of Radiofrequency Angioplasty” American Heart Journal vol. 117, pp. 332-341, 1982.
BiLAP Generator Settings, Jun. 1991.
BiLAP IFU 910026-001 Rev A for BiLAP Model 3525, J-Hook, 4 pgs, May 20, 1991.
BiLAP IFU 910033-002 Rev A for BiLAP Model 3527, L-Hook; BiLAP Model 3525, J-Hook; BiLAP Model 3529, High Angle, 2 pgs, Nov. 30, 1993.
Codman & Shurtleff, Inc. “The Malis Bipolar Coagulating and Bipolar Cutting System CMC-II” brochure, early, 2 pgs, 1991.
Codman & Shurtleff, Inc. “The Malis Bipolar Electrosurgical System CMC-III Instruction Manual” , 15 pgs, Jul. 1991.
Cook et al., “Therapeutic Medical Devices: Application and Design” , Prentice Hall, Inc., 3pgs, 1982.
Dennis et al. “Evolution of Electrofulguration in Control of Bleeding of Experimental Gastric Ulcers,” Digestive Diseases and Sciences, vol. 24, No. 11, 845-848, Nov. 1979.
Dobbie, A.K., “The Electrical Aspects of Surgical Diathermy, Bio Medical Engineering” Bio-Medical Engineering vol. 4, pp. 206-216, May 1969.
Elsasser, V.E. et al., “An Instrument for Transurethral Resection without Leakage of Current” Acta Medicotechnica vol. 24, No. 4, pp. 129-134, 1976.
Geddes, “Medical Device Accidents: With Illustrative Cases” CRC Press, 3 pgs, 1998.
Honig, W., “The Mechanism of Cutting in Electrosurgery” IEEE pp. 58-65, 1975.
Kramolowsky et al. “The Urological App of Electorsurgery” J. of Urology vol. 146, pp. 669-674, 1991.
Kramolowsky et al. “Use of 5F Bipolar Electrosurgical Probe in Endoscopic Urological Procedures” J. of Urology vol. 143, pp. 275-277, 1990.
Lee, B et al. “Thermal Compression and Molding of Artherosclerotic Vascular Tissue with Use” JACC vol. 13(5), pp. 1167-1171, 1989.
Letter from Department of Health to Jerry Malis dated Jan. 24, 1991, 3 pgs.
Letter from Department of Health to Jerry Malis dated Jul. 25, 1985, 1 pg.
Letter from Jerry Malis to FDA dated Jul. 25, 1985, 2 pgs.
Lu, et al., “Electrical Thermal Angioplasty: Catheter Design Features, In Vitro Tissue Ablation Studies and In Vitro Experimental Findings,” Am J. Cardiol vol. 60, pp. 1117-1122, Nov. 1, 1987.
Malis, L., “Electrosurgery, Technical Note,” J. Neursurg., vol. 85, pp. 970-975, Nov. 1996.
Malis, L., “Excerpted from a seminar by Leonard I. Malis, M.D. at the 1995 American Association of Neurological Surgeons Meeting,” 1pg, 1985.
Malis, L., “Instrumentation for Microvascular Neurosurgery” Cerebrovascular Surgery, vol. 1, pp. 245-260, 1985.
Malis, L., “New Trends in Microsurgery and Applied Technology,” Advanced Technology in Neurosurgery, pp. 1-16, 1988.
Malis, L., “The Value of Irrigation During Bipolar Coagulation” See ARTC 21602, 1 pg, Apr. 9, 1993.
Nardella, P.C., SPIE 1068: pp. 42-49, Radio Frequency Energy and Impedance Feedback, 1989.
O'Malley, Schaum's Outline of Theory and Problems of Basic Circuit Analysis, McGraw-Hill, 2nd Ed., pp. 3-5, 1992.
Olsen MD, Bipolar Laparoscopic Cholecstectomy Lecture (marked confidential), 12 pgs, Oct. 7, 1991.
Pearce, John A. “Electrosurgery”, pp. 17, 69-75, 87, John Wiley & Sons, New York, 1986.
Pearce, John A., “Electrosurgery”, Handbook of Biomedical Engineering, chapter 3, Academic Press Inc., N.Y., pp. 98-113, 1988.
Piercey et al., “Electrosurgical Treatment of Experimental Bleeding Canine Gastric Ulcers” Gastroenterology vol. 74(3), pp. 527-534, 1978.
Protell et al., “Computer-Assisted Electrocoagulation: Bipolar v. Monopolar in the Treatment of Experimental Canine Gastric Ulcer Bleeding,” Gastroenterology vol. 80, No. 3, pp. 451-455, 1981.
Ramsey et al., “A Comparison of Bipolar and Monopolar Diathermy Probes in Experimental Animals”, Urological Research vol. 13, pp. 99-102, 1985.
Selikowitz et al., “Electric Current and Voltage Recordings on the Myocardium During Electrosurgical Procedures in Canines,” Surgery, Gynecology & Obstetrics, vol. 164, pp. 219-224, Mar. 1987.
Shuman, “Bipolar Versus Monopolar Electrosurgery: Clinical Applications,” Dentistry Today, vol. 20, No. 12, 7 pgs, Dec. 2001.
Slager et al. “Spark Erosion of Arteriosclerotic Plaques” Z. Kardiol. 76:Suppl. 6, pp. 67-71, 1987.
Slager et al. “Vaporization of Atherosclerotice Plaques by Spark Erosion” JACC 5(6): pp. 1382-1386, Jun. 1985.
Stoffels, E. et al., “Investigation on the Interaction Plasma-Bone Tissue”, E-MRS Spring Meeting, 1 pg, Jun. 18-21, 2002.
Stoffels, E. et al., “Biomedical Applications of Plasmas”, Tutorial presented prior to the 55th Gaseous Electronics Conference in Minneapolis, MN, 41 pgs, Oct. 14, 2002.
Stoffels, E. et al., “Plasma Interactions with Living Cells”, Eindhoven University of Technology, 1 pg, 2002.
Stoffels, E. et al., “Superficial Treatment of Mammalian Cells using Plasma Needle”, J. Phys. D: Appl. Phys. 26, pp. 2908-2913, Nov. 19, 2003.
Stoffels, E. et al., “Plasma Needle”, Eindhoven University of Technology, 1 pg, Nov. 28, 2003.
Stoffels, E. et al., “Plasma Physicists Move into Medicine”, Physicsweb, 1 pg, Nov. 2003.
Stoffels, E. et al., “Plasma Treated Tissue Engineered Skin to Study Skin Damage”, Biomechanics and Tissue Engineering, Materials Technology, 1 pg, 2003.
Stoffels, E. et al., “Plasma Treatment of Dental Cavities: a Feasibility Study”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1540-1542, Aug. 2004.
Stoffels, E. et al., “The Effects of UV Irradiation and Gas Plasma Treatment on Living Mammalian Cells and Bacteria: a Comparative Approach”, IEEE Transaction on Plasma Science, vol. 32, No. 4, pp. 1544-1550, Aug. 2004.
Stoffels, E. et al., “Electrical and Optical Characterization of the Plasma Needle”, New Journal of Physics 6, pp. 1-14, Oct. 28, 2004.
Stoffels, E. et al., “Where Plasma Meets Plasma”, Eindhoven University of Technology, 23 pgs, 2004.
Stoffels, E. et al., “Gas Plasma effects on Living Cells”, Physica Scripta, T107, pp. 79-82, 2004.
Stoffels, E. et al., “Plasma Treatment of Mammalian Vascular Cells: a Quantitative Description”, IEEE Transaction on Plasma Science, vol. 33, No. 2, pp. 771-775, Apr. 2005.
Stoffels, E. et al., “Deactivation of Escherichia coli by the Plasma Needle”, J. Phys. D: Appl. Phys. 38, pp. 1716-1721, May 20, 2005.
Stoffels, E. et al., “Development of a Gas Plasma Catheter for Gas Plasma Surgery”, XXVIIth ICPIG, Endoven University of Technology, pp. 18-22, Jul. 2005.
Stoffels, E. et al., “Development of a Smart Positioning Sensor for the Plasma Needle”, Plasma Sources Sci. Technol. 15, pp. 582-589, Jun. 27, 2006.
Stoffels, E. et al., Killing of S. Mutans Bacteria Using a Plasma Needle at Atmospheric Pressure, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1317-1324, Aug. 2006.
Stoffels, E. et al., “Plasma-Needle Treatment of Substrates with Respect to Wettability and Growth of Excherichia coli and Streptococcus mutans”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1325-1330, Aug. 2006.
Stoffels, E. et al., “Reattachment and Apoptosis after Plasma-Needle Treatment of Cultured Cells”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1331-1336, Aug. 2006.
Stoffels, E. et al., “UV Excimer Lamp Irradiation of Fibroblasts: The Influence on Antioxidant Homostasis”, IEEE Transaction on Plasma Science, vol. 34, No. 4, pp. 1359-1364, Aug. 2006.
Stoffels, E. et al., “Plasma Needle for In Vivo Medical Treatment: Recent Developments and Perspectives”, Plasma Sources Sci. Technol. 15, pp. S169-S180, Oct. 6, 2006.
Swain, C.P., et al., “Which Electrode, a Comparison of four endoscopic methods of electrocoagulation in experimental bleeding ulcers” Gut vol. 25, pp. 1424-1431, 1987.
Tucker, R. et al., Abstract p. 14-11, p. 248, “A Bipolar Electrosurgical Turp Loop”, Nov. 1989.
Tucker, R. et al. “A Comparison of Urologic Application of Bipolar Versus Monopolar Five French Electrosurgical Probes” J. of Urology vol. 141, pp. 662-665, 1989.
Tucker, R. et al. “In vivo effect of 5 French Bipolar and Monopolar Electrosurgical Probes on the Porcine Bladder” Urological Research vol. 18, pp. 291-294, 1990.
Tucker, R. et al., “Demodulated Low Frequency Currents from Electrosurgical Procedures,” Surgery, Gynecology and Obstetrics, 159:39-43, 1984.
Tucker et al. “The interaction between electrosurgical generators, endoscopic electrodes, and tissue,” Gastrointestinal Endoscopy, vol. 38, No. 2, pp. 118-122, 1992.
Valley Forge Scientific Corp., “Summary of Safety and Effective Information from 510K”, 2pgs, 1991.
Valley Forge's New Products, Clinica, 475, 5, Nov. 6, 1991.
Valleylab SSE2L Instruction Manual, 11 pgs, Jan. 6, 1983.
Valleylab, Inc. “Valleylab Part No. 945 100 102 A” Surgistat Service Manual, pp. 1-46, Jul. 1988.
Wattiez, Arnaud et al., “Electrosurgery in Operative Endoscopy,” Electrosurgical Effects, Blackwell Science, pp. 85-93, 1995.
Wyeth, “Electrosurgical Unit” pp. 1181-1202, 2000.
Buchelt, et al. “Excimer Laser Ablation of Fibrocartilage: an In Vitro and In Vivo Study”, Lasers in Surgery and Medicine, vol. 11, pp. 271-279, 1991.
Costello et al., “Nd: YAG Laser Ablation of the Prostate as a Treatment for Benign Prostatic Hypertrophy”, Lasers in Surgery and Medicine, vol. 12, pp. 121-124, 1992.
O'Neill et al., “Percutaneous Plasma Discectomy Stimulates Repair in Injured Porcine Intervertebral Discs”, Dept. of Orthopaedic Surgery, Dept. of Radiology University of California at San Francisco, CA, 3 pgs No date.
Rand et al., “Effect of Elecctrocautery on Fresh Human Articular Cartilage”, J. Arthro. Surg., vol. 1, pgs. 242-246, 1985.
European Examination Report for EP 02773432 4 pgs. Sep. 22, 2009.
European Examination Report for EP 05024974 4 pgs, Dec. 5, 2008.
European Examination Report (1st) for EP 04708664 7pgs, Sep. 7, 2009.
European Examination Report for EP 02749601.7 4pgs, Dec. 2, 2009.
European Examination Report (2nd) for EP 04708664 5pgs, May 3, 2010.
European Examination Report (3rd) for EP 04708664 6pgs, Nov. 6, 2012.
European Search Report for EP 02773432 3pgs, Dec. 19, 2008.
European Search Report for EP 04708664.0 5pgs, Apr. 6, 2009.
European Search Report for EP 98953859, 2 pgs, Jul. 2, 2001.
Suppl European Search Report for EP 98953859, 3 pgs, Oct. 18, 2001.
Extended European Search Report for EP09152846, 8pgs, Jan. 5, 2010.
European Search Report for EP 99945039.8, 3 pgs, Oct. 1, 2001.
European Search Report for EP 09152850, 2 pgs, Dec. 29, 2009.
PCT International Preliminary Examination Report for PCT/US02/19261, 3pgs, Mar. 25, 2003.
PCT International Search Report for PCT/US02/19261, 1 pg, Mailed Sep. 18, 2002.
PCT International Search Report for PCT/US02/29476, 1 pg, Mailed May 24, 2004.
PCT International Search Report for PCT/US03/13686, 1 pg Mailed Nov. 25, 2003.
PCT International Search Report for PCT/US04/03614, 1 pg, Mailed Sep. 14, 2004.
PCT International Search Report for PCT/US98/22323, 1 pg, Mailed Mar. 3, 1999.
PCT International Search Report for PCT/US99/14685, 1 pg, Mailed Oct. 21, 1999.
PCT International Search Report for PCT/US99/18289, 1 pg, Mailed Dec. 7, 1999.
PCT Notification of International Preliminary Examination Report for PCT/US98/22323, 5 pgs, Mailed Nov. 28, 2000.
PCT Notification of International Preliminary Examination Report for PCT/US99/14685, 4 pgs, Mailed Feb. 20, 2001.
PCT Notification of International Preliminary Examination Report for PCT/US99/18289, 4 pgs, Mailed Jul. 7, 2000.
PCT Notification of International Search Report and Written Opinion for PCT/US06/26321, 8pgs, Mailed Apr. 25, 2007.
PCT Notification of the International Search Report and Written Opinion for PCT/US06/60618, 7pgs Mailed Oct. 5, 2007.
PCT Notification of the International Search Report and Written Opinion for PCT/US07/69856, 7pgs Mailed Jun. 5, 2008.
PCT Written Opinion of the International Searching Authority for PCT/US04/03614, 4 pgs, Mailed Sep. 14, 2004.
PCT Notification of the International Search Report and Written Opinion for PCT/US2011/033784 11 pgs, Mailed Jul. 18, 2011.
PCT Notification of the International Search Report and Written Opinion for PCT/US2011/033761 11 pgs, Mailed Jul. 22, 2011.
UK Search Report for GB0800129.9 2pgs, May 8, 2008.
UK Search Report for GB0805062.7 1 pg, Jul. 16, 2008.
UK Search Report for GB0900604.0 4 pgs, May 15, 2009.
UK Search Report for GB1110342.1 3pgs, Oct. 18, 2011.
UK Suppl Search Report for GB1110342.1 2pgs, Aug. 16, 2012.
Slager et al., “Electrical nerve and Muscle Stimulation by Radio Frequency Surgery: Role of Direct Current Loops Around the Active Electrode”, IEEE Transactions on Biomedical engineering, vol. 40, No. 2, pp. 182-187, Feb. 1993.
UK Combined Search and Exam Report for GB1403997.8 5pgs, Sep. 17, 2014.
Elgrabli, D., Abella-Gallart, S., Aguerre-Chariol, O., Robidel F.R., Boczkowski, J., Lacroix, G. (2007). Effect of BSA on carbon nanotube dispersion in vivi and in vitro studies. vol. 1, No. 4, pp. 266-278.
“Work functions for photoelectric effect”. (2001). Retrieved on Jun. 11, 2014 from http://hyperphysics.phyastr.gsu.edu/hbase/tables/photoelec.html.
Wikipedia Field Electron Emission. Retrieved on Dec. 29, 2014 from http://en.wikipedia.org/wiki/Field—electron—emission.
Refractory Metal alloys Metallurgy and Technology7: Proceedings of a Symposium on Metallurgy and Tech of Refractory Metals held in Washington, D.C., Apr. 25-26, 1968. Google ebook retried on Apr. 27, 2015 from http://books,google.com/books?id=bcPeBwAAQBAJ&dq=doping+metallurgy&source=gbs—navlinks—s.
Khanna, Work Function in Alkali and Noble Metals. 1980. Phys. Stat. Sol (b) 100,315.
Related Publications (1)
Number Date Country
20140276725 A1 Sep 2014 US